GMED·Globus Medical Inc. Class A
GMED|Analyst Targets
GMED|Insider Trading
GMED|Fundamentals
GMED|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.20 | - | - |
| Q3'25 | $0.78 | $1.18 | +51.1% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $808M | - | - |
| Q3'25 | - | $769M | - |
GMED|Monthly Returns
Market Data
GMED Stock Snapshot
- Market cap
- 10.02B
- P/E ratio
- 18.7
- Day range
- $74.98 – $76.71
- News sentiment
- 62/100 · Bullish
- Analyst target
- $100.92 (+32.2%)
- Consensus
- Buy · 25 analysts
GMED's technical picture is constructive, with trend and momentum pointing the same direction. Earnings and guidance carry more weight than macro data at this capitalisation.
Behaviour On Record
What GMED's own history says about today's numbers
- Realized volatility (21d)
- 29.1% 50th pct
- Below its peak
- -24.6%
- vs 200-day average
- -11.7%
- Up days (1y)
- 47%
Globus Medical Inc. Class A is currently running 29.1% annualised volatility over the last 21 sessions. Measured against GMED's own 13 years of daily returns rather than a market-wide average, that is the 50th percentile — close to its own typical level, against a typical reading of 28.9%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
GMED is trading -24.6% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -27.2%, and the deepest was -45.0% in 2023. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits -11.7% from its 200-day moving average. Against every other day in its history, that gap ranks at the 15th percentile — a narrower gap than it typically runs. Over the past year GMED closed higher on 47% of sessions, and it is currently 1 session into a rising streak.
On October specifically: over 13 years of records, GMED finished the month higher 9 of 13 times, with a median return of +4.7% and an average of +3.6%. Its strongest month historically has been November at +8.6% on average, its weakest September at -3.1%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: GMED has opened more than 2% away from the prior close in 192 of 3,266 sessions (5.9% of the time), with the largest gaps running +17.5% and -13.0%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,267 daily closes between 2013-10-14 and 2026-10-09, split-adjusted, recomputed daily. Percentiles are against GMED's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of GMED's sector?
Globus Medical Inc. Class A sits in the Health Care sector, currently ranked 4th of 12 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #4 of 12
- Sector state
- Improving
- Sector rotation score
- 73
Analyst Rating Changes
Are analysts turning bullish or bearish on GMED?
RBC Capital most recently reiterated its rating on Globus Medical Inc. Class A to Outperform on Oct 1, 2026 with a price target of $85 (from $115). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- RBC Capital — Outperform
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
ETF holders
ETFs holding GMED
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▼ Sell | 10,549,455 | 8.03% | $921.07M | 2026-01-29 |
| BlackRock, Inc. | ▲ Buy | 10,806,724 | 8.23% | $853.84M | 2026-08-07 |
| Janus Henderson Group plc | ▲ Buy | 7,623,095 | 5.80% | $656.83M | 2026-05-18 |
| Invesco Ltd. | ▼ Sell | 4,309,771 | 3.28% | $340.52M | 2026-08-14 |
| JPMorgan Chase & Co | ▲ Buy | 2,743,850 | 2.09% | $230.76M | 2026-08-12 |
| AllianceBernstein L.P. | ▲ Buy | 2,380,344 | 1.81% | $205.09M | 2026-08-14 |
| Geode Capital Management, LLC | ▲ Buy | 2,153,014 | 1.64% | $170.15M | 2026-08-12 |
| Goldman Sachs Group Inc | ▲ Buy | 1,781,608 | 1.36% | $140.76M | 2026-08-14 |
| William Blair Investment Management, LLC | ▼ Sell | 1,284,896 | 0.98% | $101.52M | 2026-08-12 |
| Norges Bank | ▲ Buy | 1,127,051 | 0.86% | $89.05M | 2026-08-12 |
| Morgan Stanley | ▲ Buy | 1,094,753 | 0.83% | $86.50M | 2026-08-13 |
| Wells Fargo & Company | ▲ Buy | 996,617 | 0.76% | $78.74M | 2026-08-14 |
| Northern Trust Corp | ▲ Buy | 880,633 | 0.67% | $69.58M | 2026-08-13 |
| FMR LLC (Fidelity) | ▲ Buy | 768,051 | 0.58% | $60.68M | 2026-08-13 |
| Bank of America Corp | ▲ Buy | 737,113 | 0.56% | $58.24M | 2026-08-14 |
| Capital World Investors | ▲ Buy | 590,612 | 0.45% | $46.66M | 2026-08-12 |
| Bares Capital Management, Inc. | ▲ New | 521,129 | 0.40% | $29.85M | 2025-11-14 |
| Bridgewater Associates, LP | ▲ Buy | 351,974 | 0.27% | $27.81M | 2026-08-14 |
| Gotham Asset Management, LLC | ▲ Buy | 283,058 | 0.22% | $22.36M | 2026-08-14 |
| Renaissance Technologies LLC | ▼ Sell | 196,918 | 0.15% | $15.56M | 2026-08-13 |
| Marshall Wace, LLP | ▼ Sell | 188,541 | 0.14% | $14.90M | 2026-08-13 |
| Man Group plc | ▲ Buy | 55,320 | 0.04% | $4.37M | 2026-08-14 |
| Prudential Financial Inc | ▼ Sell | 54,256 | 0.04% | $4.29M | 2026-08-12 |
| AQR Capital Management LLC | ▼ Sell | 36,534 | 0.03% | $2.85M | 2026-08-14 |
| Wellington Management Group LLP | ▲ Buy | 35,066 | 0.03% | $2.77M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-09-03 | 2026-10-12 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $15K - $50K | 2026-08-19 | 2026-09-10 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-07-10 | 2025-08-13 |
| Josh Gottheimer | House | NJ05 | ▼ Sell | $1K - $15K | 2025-04-09 | 2025-05-14 |
| Thom Tillis | Senate | NC | ▼ Sell | $1K - $15K | 2015-02-13 | 2015-02-26 |